Skip to content
Home/Companies/Biotech/ReproNovo
RE

ReproNovo

Biotech·Switzerland·Active·2yr hold

ReproNovo is a healthcare company, headquartered in France.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns ReproNovo?

ReproNovo is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2024. Across its history, ReproNovo has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito II · 2026 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Jeito Capital and ALSA Ventures since 2024.
Co-invest · 2 holders · 2024 · present
Jeito Capital
Jeito CapitalActive
2024 · present · Jeito II · 2026 · VC
MOIC
–
ALSA Ventures
ALSA VenturesActive
2025 · present · ALSA Ventures European Biotechnology Fund · 2020 · Life Sciences VC
MOIC
–

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Active
BiotechDenmark· 2026
Alveus Therapeutics
Active
BiotechUS· 2026
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025
Odyssey Therapeutics
Active
BiotechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings